Tandem Diabetes Care (MEX:TNDM) Moat Score: 6/10 (As of Jul. 12, 2026)


MEX:TNDM Tandem Diabetes Care Inc MEX:TNDM
66 GF Score
Price MXN745.00
GF Value MXN1,446.01
! 5 Warning Signs
View Full Analysis

What is Tandem Diabetes Care Moat Score?

Tandem Diabetes Care MEX:TNDM 66 Moat Score is 6 as of Jul. 12, 2026. GuruFocus rates MEX:TNDM with a GF Score™ of 66/100 and a GF Value™ of MXN1,446.01. The stock has 5 warning signs investors should review. Among 843 Medical Devices & Instruments companies, Tandem Diabetes Care ranks better than 95.73% on this metric.

Tandem Diabetes Care has the Moat Score of 6, which implies that the company might have Narrow Moat - Strong narrow moat, clearly distinguishable but not wide.

Tandem Diabetes Care has Narrow Moat: Tandem Diabetes Care has strong brand loyalty and significant customer switching costs due to its innovative diabetes management solutions. However, it faces competition and lacks regulatory barriers to ensure a wide moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Tandem Diabetes Care might have Narrow Moat - Strong narrow moat, clearly distinguishable but not wide.

Tandem Diabetes Care  (MEX:TNDM) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Tandem Diabetes Care Moat Score Related Terms

MEX:TNDM vs CNMD, AORT, LMRI: Moat Score Comparison

For the Medical Devices subindustry, Tandem Diabetes Care's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tandem Diabetes Care Moat Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tandem Diabetes Care's Moat Score distribution charts can be found below:

* The bar in red indicates where Tandem Diabetes Care's Moat Score falls into.


MEX:TNDM
66GF Score
Tandem Diabetes Care Inc MEX:TNDM
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 6 mean?
Tandem Diabetes Care (MEX:TNDM) has a Moat Score of 6 as of Jul. 12, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Tandem Diabetes Care ranks #36 out of 843 companies in the Medical Devices & Instruments industry, placing it in the top 4.3%.
Is Tandem Diabetes Care's Moat Score too high?
Tandem Diabetes Care's current Moat Score is 6. Based on the distribution chart, Tandem Diabetes Care ranks #36 out of 843 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Tandem Diabetes Care has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does Tandem Diabetes Care's Moat Score compare to CNMD and AORT?
According to the Medical Devices & Instruments industry distribution chart, Tandem Diabetes Care ranks #36 out of 843 companies for Moat Score. This places Tandem Diabetes Care in the top 4% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Devices & Instruments company?
A good Moat Score depends on the Medical Devices & Instruments industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Tandem Diabetes Care's current Moat Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tandem Diabetes Care stock overvalued right now?
Tandem Diabetes Care (MEX:TNDM) has a current Moat Score of 6. The stock's GF Value™ is MXN1,446.01, compared to a current price of MXN745.00 — trading 48.5% below its estimated fair value. The current Moat Score is 6. Tandem Diabetes Care's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Tandem Diabetes Care (MEX:TNDM), the current Moat Score is 6 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tandem Diabetes Care (MEX:TNDM) Overvalued in 2026?

Based on GuruFocus' analysis, Tandem Diabetes Care stock appears to be undervalued. The current stock price of MXN745.00 is trading 48.5% below its estimated GF Value™ of MXN1,446.01.

Key valuation signals for MEX:TNDM:

  • Moat Score: 6
  • GF Value™: MXN1,446.01 vs. price of MXN745.00 (48.5% below fair value)
  • GF Score™: 66/100 with 5 warning signs

No single metric tells the full story. See the MEX:TNDM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tandem Diabetes Care Business Description

Address 12400 High Bluff Drive, San Diego, CA, USA, 92130
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.
66GF Score

Get the complete analysis for MEX:TNDM

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN745.00
Price
MXN1,446.01
GF Value